STAT+: FDA expands Bayer lung cancer drug approval

Written and edited by the WorldPing NewsdeskPublished Updated Original reporting: STAT
STAT+: FDA expands Bayer lung cancer drug approvalWorldPing
Image via STAT.

What happened

UniQure readout tests durability of benefits, an AI effort to manage heart failure, and more biotech news from The Readout…

Key facts

  • Reported by STAT and published Thu, 10 Sep 2026 13:36:56 UTC.

Why it matters

Outbreaks, approvals and guidance changes have direct practical consequences for care, travel and public-health planning.

What to watch next

  • Case numbers and official guidance updates
  • Regulatory decisions in other countries
  • Supply, recall or access changes

Coverage timeline

When each newsroom published on this story, oldest first — all times UTC.

  1. STAT+: Cancer medicines remain in short supply across the U.S., survey finds

  2. STAT+: FDA expands Bayer lung cancer drug approval

Sources

The original report was published by STAT. WorldPing does not claim that reporting — this page summarises and contextualises it.

Read the full report at STAT

Follow the story

Living hubs that keep updating as this story develops.

Related WorldPing coverage